Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study (Pharmaceutical Research, (2019), 36, 8, (112), 10.1007/s11095-019-2651-2)

Cornelis Smit; Roeland E. Wasmann; Marinus J. Wiezer; Hendricus P.A. van Dongen; Johan W. Mouton; Roger J.M. Brüggemann; Catherijne A.J. Knibbe

doi:10.1007/s11095-020-2756-7

Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study (Pharmaceutical Research, (2019), 36, 8, (112), 10.1007/s11095-019-2651-2)

Cornelis Smit
, Roeland E. Wasmann
, Marinus J. Wiezer
, Hendricus P.A. van Dongen
, Johan W. Mouton
, Roger J.M. Brüggemann
, Catherijne A.J. Knibbe

Research output: Contribution to journal › Comment/debate

Abstract

There was a mistake in the units of CL and Q, and in the parentheses of the formula for CL in the final model in Table 2. The corrected Table appears below.

Original language	English
Article number	32
Journal	Pharmaceutical Research
Volume	37
Issue number	2
DOIs	https://doi.org/10.1007/s11095-020-2756-7
Publication status	Published - 1 Feb 2020
Externally published	Yes

Access to Document

10.1007/s11095-020-2756-7

Fingerprint

Dive into the research topics of 'Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study (Pharmaceutical Research, (2019), 36, 8, (112), 10.1007/s11095-019-2651-2)'. Together they form a unique fingerprint.

Cite this

Smit, C., Wasmann, R. E., Wiezer, M. J., van Dongen, H. P. A., Mouton, J. W., Brüggemann, R. J. M., & Knibbe, C. A. J. (2020). Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study (Pharmaceutical Research, (2019), 36, 8, (112), 10.1007/s11095-019-2651-2). Pharmaceutical Research, 37(2), Article 32. https://doi.org/10.1007/s11095-020-2756-7

Smit, Cornelis ; Wasmann, Roeland E. ; Wiezer, Marinus J. et al. / Correction to : Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study (Pharmaceutical Research, (2019), 36, 8, (112), 10.1007/s11095-019-2651-2). In: Pharmaceutical Research. 2020 ; Vol. 37, No. 2.

@article{bbf31b361f514eeea09257d1ece10628,

title = "Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study (Pharmaceutical Research, (2019), 36, 8, (112), 10.1007/s11095-019-2651-2)",

abstract = "There was a mistake in the units of CL and Q, and in the parentheses of the formula for CL in the final model in Table 2. The corrected Table appears below.",

author = "Cornelis Smit and Wasmann, \{Roeland E.\} and Wiezer, \{Marinus J.\} and \{van Dongen\}, \{Hendricus P.A.\} and Mouton, \{Johan W.\} and Br{\"u}ggemann, \{Roger J.M.\} and Knibbe, \{Catherijne A.J.\}",

note = "Publisher Copyright: {\textcopyright} 2020, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2020",

month = feb,

day = "1",

doi = "10.1007/s11095-020-2756-7",

language = "English",

volume = "37",

journal = "Pharmaceutical Research",

issn = "0724-8741",

publisher = "Springer",

number = "2",

}

Smit, C, Wasmann, RE, Wiezer, MJ, van Dongen, HPA, Mouton, JW, Brüggemann, RJM & Knibbe, CAJ 2020, 'Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study (Pharmaceutical Research, (2019), 36, 8, (112), 10.1007/s11095-019-2651-2)', Pharmaceutical Research, vol. 37, no. 2, 32. https://doi.org/10.1007/s11095-020-2756-7

Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study (Pharmaceutical Research, (2019), 36, 8, (112), 10.1007/s11095-019-2651-2). / Smit, Cornelis; Wasmann, Roeland E.; Wiezer, Marinus J. et al.
In: Pharmaceutical Research, Vol. 37, No. 2, 32, 01.02.2020.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study (Pharmaceutical Research, (2019), 36, 8, (112), 10.1007/s11095-019-2651-2)

AU - Smit, Cornelis

AU - Wasmann, Roeland E.

AU - Wiezer, Marinus J.

AU - van Dongen, Hendricus P.A.

AU - Mouton, Johan W.

AU - Brüggemann, Roger J.M.

AU - Knibbe, Catherijne A.J.

PY - 2020/2/1

Y1 - 2020/2/1

N2 - There was a mistake in the units of CL and Q, and in the parentheses of the formula for CL in the final model in Table 2. The corrected Table appears below.

AB - There was a mistake in the units of CL and Q, and in the parentheses of the formula for CL in the final model in Table 2. The corrected Table appears below.

UR - https://www.scopus.com/pages/publications/85077550247

U2 - 10.1007/s11095-020-2756-7

DO - 10.1007/s11095-020-2756-7

M3 - Comment/debate

C2 - 31919778

AN - SCOPUS:85077550247

SN - 0724-8741

VL - 37

JO - Pharmaceutical Research

JF - Pharmaceutical Research

IS - 2

M1 - 32

ER -

Smit C, Wasmann RE, Wiezer MJ, van Dongen HPA, Mouton JW, Brüggemann RJM et al. Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study (Pharmaceutical Research, (2019), 36, 8, (112), 10.1007/s11095-019-2651-2). Pharmaceutical Research. 2020 Feb 1;37(2):32. doi: 10.1007/s11095-020-2756-7